“Pharmacogenomics Education: International Society of Pharmacogenomics Recommendations for Medical, Pharmaceutical, and Health Schools Deans of Education” Gurwitz D. and Al. The Pharmacogenomics Journal (2005) 5, 221-225

Santorini Conference on Prospective Biology - Round Table Report, Pharmacogenomics, 2011, 12 (5), 597-610 (Santorini, 30th September – 2nd October 2010)

An update from The European Society of Pharmacogenomics and Theranostics. Pharmacogenomics (2012) 13(2):133-135

Recommendation of the European Society of Pharmacogenomics and Theranostics, Albertini L. and Al. Drug Metab. Drug Interact (2012) 27(2):119

Pharmacogenomics and Theranostics in practice – A summary of the Euromedlab-ESPT (The European Society of Pharmacogenomics and Theranostics) satellite symposium, May 2013. EjIFCC 2013 Vol;24, n. 3-4

Implementation of a companion diagnostic in the clinical laboratory: The BRAF example in melanoma; Clin Chim Acta. 2015 Jan 15;439:128-36.

Clinical Application Of Pharmacogenetics: Where Are We Now? EjIFCC 2013 Vol;24, n. 3-4

Second International ESPT Meeting - Lisbon, Portugal, 26–28 September 2013: Pharmacogenomics: from cell to clinic (Part 1 and 2). Pharmacogenomics (2014) 15(5), 593–599; Pharmacogenomics (2014) 15(6), 739–744

Conference Scene: Systems medicine, personalized health and therapy. Pharmacogenomics (2015) 16(14):1527-39